Insider · CIK 0001748177
Bahram Valamehr
ceopresidentofficerdirector
Files at FATE (FATE THERAPEUTICS INC). First filing Jan 13, 2025, latest Jan 12, 2026.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 3
$0 bought, $34k sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
FATE: FATE THERAPEUTICS INC
FATEOct 9, 2026 · close 2.18
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 33Weak | FATE THERAPEUTICS INC | $5,557 5,190 shares | -2% | +54% from low-39% from high | |
| 33Weak | FATE THERAPEUTICS INC | $15k 14,466 shares | -4% | +56% from low-74% from high | |
| 40Moderate | FATE THERAPEUTICS INC | $13k 8,705 shares | -2% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 15, 2026 | FATE FATE THERAPEUTICS INC | AGrant or award Common Stock | +335,000 | $0.00 | $0 | 664,708 | Jan 16, 2026 |
| Jan 15, 2026 | FATE FATE THERAPEUTICS INC | AGrant or award Stock Option (Right to Buy)derivative | +1,300,000 | $0.00 | $0 | 1,300,000 | Jan 16, 2026 |
| Jan 9, 2026 | FATE FATE THERAPEUTICS INC | SOpen-market sale Common Stock | -5,190 | $1.07 | $5,557 | 329,708 | Jan 12, 2026 |
| Aug 4, 2025 | FATE FATE THERAPEUTICS INC | SOpen-market sale Common Stock | -14,466 | $1.06 | $15k | 334,898 | Aug 5, 2025 |
| Jan 16, 2025 | FATE FATE THERAPEUTICS INC | AGrant or award Stock Option (Right to Buy)derivative | +1,300,000 | $0.00 | $0 | 1,300,000 | Jan 16, 2025 |
| Jan 10, 2025 | FATE FATE THERAPEUTICS INC | SOpen-market sale Common Stock | -8,705 | $1.54 | $13k | 349,364 | Jan 13, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.